Swedish Cancer Institute in Seattle, US, the largest cancer institution in the Providence Health and Services network, has chosen RayStation as its primary comprehensive treatment planning system.
RayStation has been in use at other Providence Health and Services network hospitals since 2013. Swedish Cancer Institute's order places the center as the 8th RayStation user within the Providence system, allowing these centers to share data as needed, enabling centralized operations and access.
The purchase solidifies Providence Health and Services’ commitment to fostering an approach that takes advantage of the treatment planning efficiencies RayStation can provide on an enterprise level.
RayStation was selected by Swedish Cancer Institute following an evaluation of leading treatment planning systems on the market. Key factors in the decision included the system’s high efficiency and cutting-edge functionality such as multi-criteria optimization (MCO), adaptive planning, dose tracking and fallback planning.
Dave Shepard, Director of Medical Physics at Swedish Cancer Institute, says: “As with many large radiation therapy treatment networks around the US, we have a need to consolidate our technical approach to treatment planning. We also needed to support several different linear accelerator vendors and patient data from disparate systems. Our goal is to become more efficient, at several different levels, while not compromising any aspect of patient care.”
Johan Löf, CEO of RaySearch, says: “We are very pleased that Providence Health and Services network has chosen RayStation to continue their integration efforts. Our team will work hard to support the Swedish Cancer Institute, and we are confident that RayStation will deliver outstanding clinical efficiency, high speed and adaptive treatment workflows, and ensure the best possible treatment for its many patients. It is also rewarding to deliver our system to a center founded by a fellow Swedish doctor almost 90 years ago. We are excited to see the future of our collaboration with Swedish Cancer Institute and the Providence Health and Services network."
About Swedish Cancer Institute
Since 1910, Swedish Hospital has been the Seattle area's hallmark for excellence in hospitals and health care. Swedish is consistently named the Seattle area's best hospital, with the best doctors, nurses and overall care in a variety of specialty areas. The cancer center, Swedish Cancer Institute, has been a Seattle-area leader in innovative cancer diagnosis, treatment and recovery since 1932. The center is said to have cared for more patients than any other cancer center in the Northwest.
RayCare* represents the future of OIS technology, developed from the ground up by RaySearch to support the complex logistical challenges of modern, large-scale radiation therapy centers. RayCare will integrate the high-performance radiation therapy algorithms available in RayStation with advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy.
RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability.
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system and the RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003.
More information about RaySearch is available at www.raysearchlabs.com
* Subject to regulatory clearance in some markets.
For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00
Peter Thysell, CFO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)70 661 05 59